Galia D Napchan Pomerantz, MD

Specialties
Pediatric Pulmonology, Cystic Fibrosis
Primary Office
Address 1131 N. 35th Avenue
3rd Floor
Hollywood, FL 33021
Phone: 954-265-6333
Fax: 954-961-7027
Primary Office
Address 1131 N. 35th Avenue
Suite 330
Hollywood, FL 33021
Phone: 954-265-6333
Fax: 954-961-7027

About Me

Medical Director, Pulmonary Neuromuscular Services Program 

Dr. Galia Napchan Pomerantz is a pediatric pulmonologist at the Division of Pediatric Pulmonology at Joe DiMaggio Children's Hospital Cystic Fibrosis and Pulmonary Center. She received her medical degree from the University of Buenos Aires and completed a residency at the Ricardo Gutierrez Children's Hospital in Buenos Aires, Argentina. She then completed a pediatric residency and a fellowship in pediatric pulmonology at Jackson Memorial Hospital /University of Miami Miller School of Medicine.

Prior to coming to Joe DiMaggio Children's Hospital, Dr. Napchan Pomerantz was Assistant Professor of Pediatrics at the University of Miami's Miller School of Medicine for five years. During that time, she was also the Director of the Asthma Center and the Infant Pulmonary Function Test Laboratory of the Department of Pediatric Pulmonology at Jackson Memorial Hospital. 

Related Medical Services

Education

Education
  • Universidad De Buenos Aires, 1992
Residencies
  • Univ Of Miami-Jackson Memorial Med Ctr, 2004, Pediatrics
Fellowships
  • Jackson Memorial Hospital, 2002, Pediatric Pulmonology
Certifications
  • American Board of Pediatrics-Pediatric Pulmonology
  • American Board of Pediatrics-Pediatrics
Languages
  • Spanish

Professional Highlights

Awards

  • American Thoracic Society Travel Award Grant, 2002

Professional Organizations

  • American Academy of Pediatrics
  • Co-Investigator, Double-Blind, Multicenter, Randomized, Placebo-Controlled Study on Acid Reflux in Asthma
  • Co-Investigator, A Phase 3, Double-Blind, Multicenter, Randomized, Placebo-Controlled Trial with Aztreonam Lysinate for Inhalation in Cystic Fibrosis Patients with Pulmonary P Aeruginosa Requiring Frequent Antibiotics
  • Co-Investigator, A Pivotal Phase 3 Study of MEDI-524 (Numax), an Enhanced Potency Humanized Respiratory Syncytial Virus (RSV) Monoclonal Antibody, for the Prophylaxis of Serious RSV Disease in High-Risk Children
  • Co-Investigator, HealthSpark 2: Improving Asthma Care for Preschool Children

Presentations

  • “Hemoptysis in Children,” Master of Pediatrics, 2008
  • “Asthma Therapy,” Master of Pediatrics, 2007

Related Physicians